bioRxiv Science⌕ Search

Biology subjects

Ballinger, T.

Publications and source records attributed to Ballinger, T..

4 recordsLinked to original sources

Understanding when and how knowledge graphs add value to EHR-based clinical prediction across Parkinson's disease, multiple sclerosis, and chronic pain

Biomedical knowledge graphs (KGs) have emerged as a promising approach for incorporating biological knowledge into machine-learning models trained on electronic health record (EHR) data. However, their large scale and heterogeneous structure impose substantial computational cost, and it remains unclear whether their benefits generalize across diseases or depend on how the graph is constructed. We systematically evaluated KG integration across three diseases spanning distinct biological and clinical characteristics: multiple sclerosis, Parkinson's disease, and chronic pain. For each disease we compared five modelling strategies, spanning EHR-only features and graph diffusion over concept-level, cohort-derived, disease-anchored, and full SPOKE (Scalable Precision Medicine Open Knowledge Engine) subgraphs, asking whether graph construction affects predictive performance and computational cost, whether KG integration improves classification over EHR-only models, and what the graph does to model behavior. Cohort-derived subgraphs, comprising roughly 45% of SPOKE's nodes and one-fifth of its edges, matched or modestly exceeded the full graph's performance while substantially reducing computational cost in all three diseases. The predictive benefit of KG integration, however, was strongly disease-dependent: it improved classification in Parkinson's disease, had no measurable effect in multiple sclerosis, and reduced performance in chronic pain. These differences were not explained by the amount of biological information incorporated: the disease with the largest shift toward molecular features showed no improvement, the sole beneficiary showed only a modest shift, and the disease with no molecular shift was penalized. Mechanistically, graph diffusion redistributed each disease's existing signal across many correlated features rather than adding independent biological signal, so that any gain depended on whether it added information beyond the EHR. These findings show that cohort-derived subgraphs offer a computationally efficient alternative to full-scale knowledge graphs, and that KG integration functions less as a universal accuracy booster than as a data- and disease-dependent transformation of the patient representation.

bioinformatics↗

Loss of age-accumulated crh-1 circRNAs ameliorate amyloid β-induced toxicity in a C. elegans model for Alzheimers disease

Circular RNAs (circRNAs) are non-coding RNAs mostly derived from exons of protein-coding genes via a back-splicing process. The expression of hundreds of circRNAs accumulates during healthy aging and is associated with Alzheimers disease (AD), characterized by the accumulation of amyloid-beta (A{beta}) proteins. In C. elegans, many circRNAs were previously found to accumulate during aging, with loss of age-accumulated circRNAs derived from the CREB gene (circ-crh-1) to increase mean lifespan. Here, we used C. elegans to study the effects of age-accumulated circRNAs on the age-related onset of A{beta}-toxicity. We found that circ-crh-1 mutations delayed A{beta}-induced muscle paralysis and lifespan phenotypes in a transgenic C. elegans strain expressing a full-length human A{beta}-peptide (A{beta}1-42) selectively in muscle cells (GMC101). The delayed A{beta} phenotypic defects were associated with inhibiting the deposition of A{beta} aggregates, and thus, genetic removal of circ-crh-1 provides protection against A{beta}-induced toxicity. Consistent with a detrimental role for age-accumulated circRNAs in AD, circ-crh-1 expression level is elevated after induction of A{beta} during aging, whereas linear crh-1 mRNA expression remains unchanged. Finally, we show that a circ-crh-1 upregulated collagen gene, col-49, promotes A{beta}-induced paralysis. Taken together, our results show that the loss of an age-accumulated circRNA exerts a protective role on A{beta}-induced toxicity, demonstrating the utility of C. elegans for studying circRNAs in AD and its relationship to aging.

neuroscience↗

Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer

Deciphering the structural variation across tumour genomes is crucial to determine the events driving tumour progression and better understand tumour adaptation and evolution. High grade serous ovarian cancer (HGSOC) is an exemplar tumour type showing extreme, but poorly characterised structural diversity. We comprehensively describe the mutational landscape driving HGSOC, exploiting a large (N=324), deeply whole genome sequenced dataset. We reveal two divergent evolutionary trajectories, affecting patient survival and involving differing genomic environments. One involves homologous recombination repair deficiency (HRD) while the other is dominated by whole genome duplication (WGD) with frequent chromothripsis, breakage-fusion-bridges and extra-chromosomal DNA. These trajectories contribute to structural variation hotspots, containing novel candidate driver genes with significantly altered expression. While structural variation predominantly drives tumorigenesis, we also find high mtDNA mutation loads associated with shorter patient survival, and acting in combination with alterations in the nuclear genome to impact prognosis and suggesting new strategies for patient stratification.

cancer biology↗

Heterochromatin delays CRISPR-Cas9 mutagenesis but does not influence repair outcome

CRISPR-Cas9 genome editing occurs in the context of chromatin, which is heterogeneous in structure and function across the genome. Chromatin heterogeneity is thought to affect genome editing efficiency, but this has been challenging to quantify due to the presence of confounding variables. Here, we develop a method that exploits the allele-specific chromatin status of imprinted genes in order to address this problem. Because maternal and paternal alleles of imprinted genes have identical DNA sequence and are situated in the same nucleus, allele-specific differences in the frequency and spectrum of Cas9-induced mutations can be attributed unequivocally to epigenetic mechanisms. We found that heterochromatin can impede mutagenesis, but to a degree that depends on other key experimental parameters. Mutagenesis was impeded by up to 7-fold when Cas9 exposure was brief and when intracellular Cas9 expression was low. Surprisingly, the outcome of mutagenic DNA repair was independent of chromatin state, with similar efficiencies of homology directed repair and deletion spectra on maternal and paternal chromosomes. Combined, our data show that heterochromatin imposes a permeable barrier that influences the kinetics, but not the endpoint of CRISPR-Cas9 genome editing, and suggest that therapeutic applications involving low-level Cas9 exposure will be particularly affected by chromatin status.

genetics↗